You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 21, 2025

Drug Price Trends for FIRST AID ANTISEPTIC


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for FIRST AID ANTISEPTIC

Average Pharmacy Cost for FIRST AID ANTISEPTIC

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
FIRST AID ANTISEPTIC 10% OINT 00536-1271-80 0.05053 GM 2024-12-18
FIRST AID ANTISEPTIC 10% OINT 00536-1271-80 0.05106 GM 2024-11-20
FIRST AID ANTISEPTIC 10% OINT 00536-1271-80 0.04947 GM 2024-10-23
FIRST AID ANTISEPTIC 10% OINT 00536-1271-80 0.05111 GM 2024-09-18
FIRST AID ANTISEPTIC 10% OINT 00536-1271-80 0.04843 GM 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for First Aid Antiseptics

Introduction to First Aid Antiseptics

First aid antiseptics are crucial in preventing infections and promoting wound healing. These products are widely used in various settings, including homes, workplaces, and healthcare facilities. Here’s a comprehensive analysis of the market and price projections for first aid antiseptics.

Global Market Size and Growth

The global antiseptic and disinfectant market, which includes first aid antiseptics, is experiencing significant growth. As of 2023, the market size was estimated at USD 31.4 billion and is projected to grow at a CAGR of 10.8% from 2024 to 2030[1].

Key Drivers of Market Growth

Several factors are driving the growth of the first aid antiseptic market:

Increasing Incidence of Diseases

The rise in diseases such as typhoid, hepatitis A, cholera, and dengue, largely due to poor hygiene and food poisoning, is a major driver. For instance, the World Health Organization (WHO) reported around 7.6 million dengue cases in 2024, highlighting the need for effective antiseptics[1].

Healthcare-Associated Infections (HAIs)

The increasing incidence of HAIs in hospitals and clinics is another significant factor. According to the WHO, approximately 15 out of 100 patients in low- and middle-income countries and 7 out of 100 in high-income countries developed HAIs during their acute care hospital stay[1].

Antimicrobial Resistance (AMR)

The rise of antimicrobial resistance (AMR) is pushing the demand for advanced antiseptic formulations. Collaborative efforts between researchers, healthcare providers, and industry players are essential in developing innovative solutions to combat resistant strains[4].

Market Segmentation

By Type

Quaternary ammonium compounds dominate the antiseptic and disinfectant market, holding around 31.4% of the market share in 2023. These compounds are widely used as surface disinfectants in hospitals and laboratories and for disinfecting medical equipment[1].

By Application

The hospital segment dominated the market in 2023, driven by the increasing incidence of HAIs and the need for strict hygiene standards. Increasing healthcare expenditure and the growing number of hospitals are expected to propel this segment's growth[1].

Regional Analysis

North America

North America leads the antiseptic and disinfectant market due to high healthcare standards, stringent regulations, and heightened consumer awareness. The region accounted for 34.3% of the global market revenue in 2023[1].

India and Middle East & Africa

The Indian market is driven by rising awareness about the benefits of antiseptics, the growing number of healthcare facilities, and the development of new solutions. The Middle East and Africa region is expected to grow due to increasing awareness about home cleanliness and rising healthcare expenditures by governments[1].

Price Projections

The prices of first aid antiseptics are influenced by several factors, including raw material costs, regulatory compliance, and market demand.

Current Market Prices

In 2019, the sales of leading first aid ointment brands in the U.S. indicated a significant market presence. For example, Neosporin Plus, a popular first aid ointment, generated sales of approximately $100.3 million[5].

Future Price Trends

Given the projected growth of the antiseptic and disinfectant market, prices are likely to remain competitive but may increase slightly due to the development of advanced formulations and rising raw material costs. The market is expected to reach USD 61.2 billion by 2031, growing at a CAGR of 7.0% from 2023 to 2031[4].

Key Players and Product Innovations

Several key players dominate the market, including Johnson & Johnson, 3M Co, and Coloplast A/S ADR. These companies are continuously innovating, such as the launch of MedLife Formulations Pvt. Ltd.'s 4-in-1 antiseptic solution, Septicol Antiseptic Liquid, which can be used for both surface cleaning and first aid treatments[1].

Impact of Regulatory Standards

Stringent regulatory standards, particularly in regions like North America, play a crucial role in shaping the market. For instance, the approval of disinfectants designed to eliminate the COVID-19 virus underscored the positive impact of regulatory compliance on market growth[1].

Consumer Awareness and Education

Increasing consumer awareness about hygiene and infection prevention is driving the demand for first aid antiseptics. Educational campaigns and public health initiatives are crucial in promoting the use of these products.

"Collaborative efforts between researchers, healthcare providers, and industry players are thus crucial in developing innovative solutions" to combat antimicrobial resistance[4].

Key Takeaways

  • Market Growth: The global antiseptic and disinfectant market is expected to grow significantly, driven by increasing disease prevalence, HAIs, and AMR.
  • Regional Dominance: North America leads the market due to high healthcare standards and stringent regulations.
  • Product Innovations: Key players are innovating with advanced formulations and multi-purpose products.
  • Price Trends: Prices are expected to remain competitive but may increase due to advanced formulations and rising raw material costs.
  • Regulatory Impact: Stringent regulatory standards are crucial in shaping market growth and ensuring product efficacy.

FAQs

  1. What is driving the growth of the first aid antiseptic market? The growth is driven by increasing disease prevalence, HAIs, AMR, and rising awareness about hygiene and infection prevention.

  2. Which region dominates the antiseptic and disinfectant market? North America dominates the market due to high healthcare standards, stringent regulations, and heightened consumer awareness.

  3. What types of antiseptics are most commonly used? Quaternary ammonium compounds are widely used due to their broad-spectrum effectiveness and safety for various applications.

  4. How are regulatory standards impacting the market? Stringent regulatory standards are crucial in ensuring product efficacy and compliance, which positively impacts market growth.

  5. What is the projected market size for antiseptics and disinfectants by 2031? The market is expected to reach USD 61.2 billion by 2031, growing at a CAGR of 7.0% from 2023 to 2031[4].

Sources

  1. Grand View Research - Antiseptic And Disinfectant Market Size & Share Report 2030
  2. Grand View Research - North America First Aid Market Size & Outlook, 2023-2030
  3. Allied Market Research - Povidone Iodine Market Size & Share | Forecast Report 2031
  4. GlobeNewswire - Antiseptic and Disinfectant Market Size to Hit USD 61.2 billion by 2031 at 7.0% CAGR
  5. Statista - Sales of the leading first aid ointment brands in the U.S. 2019

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.